tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ALC Stock Latest News

Alcon price target lowered to CHF 90 from CHF 93 at Berenberg
The FlyAlcon price target lowered to CHF 90 from CHF 93 at Berenberg
4d ago
ALC
Alcon price target lowered to $84 from $90 at Morgan Stanley
PremiumThe Fly
Alcon price target lowered to $84 from $90 at Morgan Stanley
5d ago
ALC
Alcon price target raised to $100 from $99 at BTIG
PremiumThe Fly
Alcon price target raised to $100 from $99 at BTIG
6d ago
ALC
Alcon to acquire LumiThera, PBM device
PremiumThe Fly
Alcon to acquire LumiThera, PBM device
13d ago
ALC
Alcon price target raised to CHF 101 from CHF 99 at Citi
PremiumThe Fly
Alcon price target raised to CHF 101 from CHF 99 at Citi
1M ago
ALC
Alcon’s Stock Boosted by FDA Approval of Innovative Dry Eye Drug TRYPTYR
PremiumRatingsAlcon’s Stock Boosted by FDA Approval of Innovative Dry Eye Drug TRYPTYR
2M ago
ALC
Alcon’s Strategic Initiatives and Valuation Justify Buy Rating with $99 Price Target
Premium
Ratings
Alcon’s Strategic Initiatives and Valuation Justify Buy Rating with $99 Price Target
2M ago
ALC
Alcon Secures FDA Approval for TRYPTYR to Treat Dry Eye Disease
Premium
Company Announcements
Alcon Secures FDA Approval for TRYPTYR to Treat Dry Eye Disease
2M ago
6K
ALC
Alcon’s Tryptyr approved by FDA for signs and symptoms of Dry Eye Disease
PremiumThe Fly
Alcon’s Tryptyr approved by FDA for signs and symptoms of Dry Eye Disease
2M ago
ALC
Alcon upgraded to Buy from Hold at Kepler Cheuvreux
PremiumThe Fly
Alcon upgraded to Buy from Hold at Kepler Cheuvreux
2M ago
ALC
Lifecore initiated with an Outperform at William Blair
PremiumThe Fly
Lifecore initiated with an Outperform at William Blair
2M ago
ALC
LFCR
Alcon price target lowered to CHF 95 from CHF 100 at RBC Capital
PremiumThe Fly
Alcon price target lowered to CHF 95 from CHF 100 at RBC Capital
2M ago
ALC
Alcon downgraded to Hold from Buy at Deutsche Bank
PremiumThe FlyAlcon downgraded to Hold from Buy at Deutsche Bank
2M ago
ALC
Alcon’s Earnings Call: Balancing Growth and Challenges
Premium
Company Announcements
Alcon’s Earnings Call: Balancing Growth and Challenges
2M ago
ALC
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
ALC
IEP
Alcon’s Strategic Maneuvers and Innovation Drive Buy Rating Despite Earnings Miss
PremiumRatings
Alcon’s Strategic Maneuvers and Innovation Drive Buy Rating Despite Earnings Miss
2M ago
ALC
Alcon Inc. Reports Strong Q1 2025 Earnings Growth
PremiumCompany Announcements
Alcon Inc. Reports Strong Q1 2025 Earnings Growth
2M ago
ALC
Alcon’s Resilience Amid Market Challenges: A Buy Recommendation by David Saxon
PremiumRatings
Alcon’s Resilience Amid Market Challenges: A Buy Recommendation by David Saxon
2M ago
ALC
Alcon’s Long-Term Growth Potential Outweighs Short-Term Challenges: Buy Rating Maintained
PremiumRatings
Alcon’s Long-Term Growth Potential Outweighs Short-Term Challenges: Buy Rating Maintained
2M ago
ALC
Closing Bell Movers: Exelixis up 6% on earnings beat
PremiumThe FlyClosing Bell Movers: Exelixis up 6% on earnings beat
2M ago
NU
AEO
Alcon Reports Q1 2025 Results and Launches New Ophthalmic Products
Premium
Company Announcements
Alcon Reports Q1 2025 Results and Launches New Ophthalmic Products
2M ago
6K
ALC
Alcon reports Q1 EPS 73c, consensus 76c
Premium
The Fly
Alcon reports Q1 EPS 73c, consensus 76c
2M ago
ALC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >